EMAIL THIS PAGE TO A FRIEND

Journal of neuropathology and experimental neurology

Conditional overexpression of insulin-like growth factor-1 enhances hippocampal neurogenesis and restores immature neuron dendritic processes after traumatic brain injury.


PMID 25003234

Abstract

Traumatic brain injury (TBI) is associated with neuronal damage or neuronal death in the hippocampus, a region critical for cognitive function. Immature neurons within the hippocampal neurogenic niche are particularly susceptible to TBI. Therapeutic strategies that protect immature hippocampal neurons or enhance posttraumatic neurogenesis may be advantageous for promoting functional recovery after TBI. Insulin-like growth factor-1 (IGF-1) promotes neurogenesis in the adult brain, but its effects on neurogenesis after TBI are unknown. We used an astrocyte-specific conditional IGF-1-overexpressing mouse model to supplement IGF-1 in regions of neuronal damage and reactive astrocytosis after controlled cortical impact injury. Although early loss of immature neurons was not significantly attenuated, overexpression of IGF-1 resulted in a marked increase in immature neuron density in the subgranular zone at 10 days after injury. This delayed increase seemed to be driven by enhanced neuron differentiation rather than by increased cellular proliferation. In wild-type mice, dendrites of immature neurons exhibited significant decreases in total length and number of bifurcations at 10 days after injury versus neurons in sham-injured mice. In contrast, the morphology of immature neuron dendrites in brain-injured IGF-1-overexpressing mice was equivalent to that in sham controls. These data provide compelling evidence that IGF-1 promotes neurogenesis after TBI.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

AV41333
Anti-DCX (AB1) antibody produced in rabbit, affinity isolated antibody
AV41332
Anti-DCX (AB2) antibody produced in rabbit, affinity isolated antibody
SAB2502091
Anti-Dcx antibody produced in goat, affinity isolated antibody, buffered aqueous solution
SAB2501666
Anti-DCX antibody produced in goat, affinity isolated antibody, buffered aqueous solution
SAB1405701
Anti-DCX antibody produced in mouse, purified immunoglobulin, buffered aqueous solution
D9943
Anti-Doublecortin (N-terminal) antibody produced in rabbit, ~1.5 mg/mL, affinity isolated antibody, buffered aqueous solution
D9693
Anti-Doublecortin antibody produced in rabbit, ~1 mg/mL, affinity isolated antibody, buffered aqueous solution
SAB4300697
Anti-Doublecortin antibody produced in rabbit, affinity isolated antibody
SAB4500628
Anti-Doublecortin antibody produced in rabbit, affinity isolated antibody
HPA007007
Anti-NES antibody produced in rabbit, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
HPA026111
Anti-NES antibody produced in rabbit, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
SAB2104575
Anti-NES antibody produced in rabbit, affinity isolated antibody
N5413
Anti-Nestin antibody produced in rabbit, ~1 mg/mL, affinity isolated antibody, buffered aqueous solution
WH0001641M1
Monoclonal Anti-DCX antibody produced in mouse, clone 1G12, purified immunoglobulin, buffered aqueous solution
SAB1403727 Monoclonal Anti-DCX antibody produced in mouse, clone 3B7, purified immunoglobulin, buffered aqueous solution
AMAB90556
Monoclonal Anti-NES antibody produced in mouse, Prestige Antibodies® Powered by Atlas Antibodies, clone CL0197, purified immunoglobulin, buffered aqueous glycerol solution